These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24228414)
41. [Systemic therapy of breast cancer: practice guideline]. Horváth Z; Boér K; Dank M; Kahán Z; Kocsis J; Kövér E; Pajkos G; Pikó B; Rubovszky G; Eckhardt S Magy Onkol; 2016 Sep; 60(3):241-57. PubMed ID: 27579723 [TBL] [Abstract][Full Text] [Related]
42. Possibilities for transborder cooperation in breast cancer care in Europe: a comparative analysis regarding the content, quality and evidence use of breast cancer guidelines. Wennekes L; Hermens RP; van Heumen K; Runde V; Schoelen H; Wollersheim HC; Grol RP; de Mulder PH; Ottevanger PB Breast; 2008 Oct; 17(5):464-71. PubMed ID: 18455399 [TBL] [Abstract][Full Text] [Related]
43. Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review. Dahlhaus A; Semlitsch T; Jeitler K; Horvath K; Siebenhofer A Fam Pract; 2015 Oct; 32(5):483-91. PubMed ID: 26142418 [TBL] [Abstract][Full Text] [Related]
44. [Japanese Society of Hematology conflict of interest management in medical research]. Katayama N Rinsho Ketsueki; 2018; 59(10):2390-2395. PubMed ID: 30305550 [TBL] [Abstract][Full Text] [Related]
45. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 4) The intestinal epithelial stem cells and cancer stem cells]. Tsuchiya K Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2273-8. PubMed ID: 24228411 [No Abstract] [Full Text] [Related]
46. Impact of a clinical guidelines program for breast and colon cancer in a French cancer center. Ray-Coquard I; Philip T; Lehmann M; Fervers B; Farsi F; Chauvin F JAMA; 1997 Nov; 278(19):1591-5. PubMed ID: 9370505 [TBL] [Abstract][Full Text] [Related]
47. A constraint-based approach to medical guidelines and protocols. Hommersom A; Groot P; Lucas P; Marcos M; Martínez-Salvador B Stud Health Technol Inform; 2008; 139():213-22. PubMed ID: 18806330 [TBL] [Abstract][Full Text] [Related]
48. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 2) Human leukemic stem cell]. Akashi K Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2262-6. PubMed ID: 24228409 [No Abstract] [Full Text] [Related]
49. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 3) iPS cell technology for neurodegenerative disease]. Inoue H Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2267-72. PubMed ID: 24228410 [No Abstract] [Full Text] [Related]
50. [Ten hot issues of breast cancer in diagnosis and therapy in 2018]. Jiang ZF; Li JB Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):95-100. PubMed ID: 29397620 [TBL] [Abstract][Full Text] [Related]
51. Advanced breast cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence Guideline 2009 - a solid basis for good clinical practice. Murray N; Brunt M; Macbeth F; Winstanley J; Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):368-70. PubMed ID: 19419851 [No Abstract] [Full Text] [Related]
52. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 1) Abnormalities in hematopoietic stem cells: congenital immunodeficiencies]. Hara T Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2255-61. PubMed ID: 24228408 [No Abstract] [Full Text] [Related]
53. New guidelines for HER2+ breast cancer. Cancer Discov; 2014 Jul; 4(7):OF2. PubMed ID: 25002626 [TBL] [Abstract][Full Text] [Related]
54. NCCN breast cancer clinical practice guidelines in oncology: an update. Carlson RW J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S61-3. PubMed ID: 19795577 [TBL] [Abstract][Full Text] [Related]
55. Editorial: Why are guidelines not followed in clinical practice? Cardoso F; Gennari A Breast; 2017 Apr; 32():245-246. PubMed ID: 27989669 [No Abstract] [Full Text] [Related]
56. Evaluation of guidelines regarding surgical treatment of breast cancer using the AGREE Instrument: a systematic review. Lei X; Liu F; Luo S; Sun Y; Zhu L; Su F; Chen K; Li S BMJ Open; 2017 Nov; 7(11):e014883. PubMed ID: 29138191 [TBL] [Abstract][Full Text] [Related]
57. RAPADAPTE for rapid guideline development: high-quality clinical guidelines can be rapidly developed with limited resources. Alper BS; Tristan M; Ramirez-Morera A; Vreugdenhil MM; Van Zuuren EJ; Fedorowicz Z Int J Qual Health Care; 2016 Jun; 28(3):268-74. PubMed ID: 27097885 [TBL] [Abstract][Full Text] [Related]
58. Canadian breast cancer guidelines are as effective as possible under the circumstances. Grunfeld E CMAJ; 2007 Mar; 176(6):785-6. PubMed ID: 17353531 [No Abstract] [Full Text] [Related]
59. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Invited Lecture: Recent Progress of Hypertension Diagnosis and Therapy]. Shimamoto K Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1750-60. PubMed ID: 30160860 [No Abstract] [Full Text] [Related]
60. [The German Guideline Clearinghouse on Breast Cancer: the need for frequent updating of breast cancer guidelines requires effective guideline updating procedures]. Weingart O; Sonntag D; Trapp H; Bartsch HH; Baumeister RG; Goerke K; Giersiepen K; Hindenburg HJ; Ming K; Schulz-Wendtland R; Störkel S; Kober T; Thole H; Kirchner H; Ollenschläger G; Z Arztl Fortbild Qualitatssich; 2004 Aug; 98(5):403-11. PubMed ID: 15487388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]